BioXcel Therapeutics Stock Forecast - 8 Period Moving Average
| BTAI Stock | USD 0.47 0.04 7.84% |
The 8 Period Moving Average forecasted value of BioXcel Therapeutics on the next trading day is expected to be 0.55 with a mean absolute deviation of 0.04 and the sum of the absolute errors of 2.34. BioXcel Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of BioXcel Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
BioXcel |
BioXcel Therapeutics 8 Period Moving Average Price Forecast For the 27th of November
Given 90 days horizon, the 8 Period Moving Average forecasted value of BioXcel Therapeutics on the next trading day is expected to be 0.55 with a mean absolute deviation of 0.04, mean absolute percentage error of 0, and the sum of the absolute errors of 2.34.Please note that although there have been many attempts to predict BioXcel Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that BioXcel Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
BioXcel Therapeutics Stock Forecast Pattern
| Backtest BioXcel Therapeutics | BioXcel Therapeutics Price Prediction | Buy or Sell Advice |
BioXcel Therapeutics Forecasted Value
In the context of forecasting BioXcel Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. BioXcel Therapeutics' downside and upside margins for the forecasting period are 0 and 6.78, respectively. We have considered BioXcel Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 8 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of BioXcel Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent BioXcel Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 99.4527 |
| Bias | Arithmetic mean of the errors | 0.0032 |
| MAD | Mean absolute deviation | 0.0434 |
| MAPE | Mean absolute percentage error | 0.0739 |
| SAE | Sum of the absolute errors | 2.3425 |
Predictive Modules for BioXcel Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioXcel Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for BioXcel Therapeutics
For every potential investor in BioXcel, whether a beginner or expert, BioXcel Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. BioXcel Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in BioXcel. Basic forecasting techniques help filter out the noise by identifying BioXcel Therapeutics' price trends.View BioXcel Therapeutics Related Equities
| Risk & Return | Correlation |
BioXcel Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of BioXcel Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of BioXcel Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
BioXcel Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how BioXcel Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioXcel Therapeutics shares will generate the highest return on investment. By undertsting and applying BioXcel Therapeutics stock market strength indicators, traders can identify BioXcel Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 102814.0 | |||
| Daily Balance Of Power | (0.80) | |||
| Rate Of Daily Change | 0.92 | |||
| Day Median Price | 0.48 | |||
| Day Typical Price | 0.47 | |||
| Price Action Indicator | (0.03) | |||
| Period Momentum Indicator | (0.04) | |||
| Relative Strength Index | 56.15 |
BioXcel Therapeutics Risk Indicators
The analysis of BioXcel Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in BioXcel Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bioxcel stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.54 | |||
| Standard Deviation | 6.23 | |||
| Variance | 38.83 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether BioXcel Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioXcel Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioxcel Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioxcel Therapeutics Stock:Check out Historical Fundamental Analysis of BioXcel Therapeutics to cross-verify your projections. For more detail on how to invest in BioXcel Stock please use our How to Invest in BioXcel Therapeutics guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioXcel Therapeutics. If investors know BioXcel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioXcel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.04) | Revenue Per Share 0.074 | Quarterly Revenue Growth 1.416 | Return On Assets (0.64) | Return On Equity (17.67) |
The market value of BioXcel Therapeutics is measured differently than its book value, which is the value of BioXcel that is recorded on the company's balance sheet. Investors also form their own opinion of BioXcel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is BioXcel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioXcel Therapeutics' market value can be influenced by many factors that don't directly affect BioXcel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioXcel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioXcel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioXcel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.